These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

701 related items for PubMed ID: 14567201

  • 1. The use of long-acting opioids in chronic pain management.
    Vallerand AH.
    Nurs Clin North Am; 2003 Sep; 38(3):435-45. PubMed ID: 14567201
    [Abstract] [Full Text] [Related]

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Sep; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 3. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L, Kaye AM, Knezevic NN, McAnally H, Slavin K, Trescot AM, Blank S, Pampati V, Abdi S, Grider JS, Kaye AD, Manchikanti KN, Cordner H, Gharibo CG, Harned ME, Albers SL, Atluri S, Aydin SM, Bakshi S, Barkin RL, Benyamin RM, Boswell MV, Buenaventura RM, Calodney AK, Cedeno DL, Datta S, Deer TR, Fellows B, Galan V, Grami V, Hansen H, Helm Ii S, Justiz R, Koyyalagunta D, Malla Y, Navani A, Nouri KH, Pasupuleti R, Sehgal N, Silverman SM, Simopoulos TT, Singh V, Solanki DR, Staats PS, Vallejo R, Wargo BW, Watanabe A, Hirsch JA.
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [Abstract] [Full Text] [Related]

  • 4. Patient-reported utilization patterns of fentanyl transdermal system and oxycodone hydrochloride controlled-release among patients with chronic nonmalignant pain.
    Ackerman SJ, Mordin M, Reblando J, Xu X, Schein J, Vallow S, Brennan M.
    J Manag Care Pharm; 2003 Feb; 9(3):223-31. PubMed ID: 14613465
    [Abstract] [Full Text] [Related]

  • 5.
    Kongsgaard U, Kaasa S, Dale O, Ottesen S, Nordøy T, Hessling SE, von Hofacker S, Bruland ØS, Lyngstadaas A.
    ; 2005 12. PubMed ID: 29320015
    [Abstract] [Full Text] [Related]

  • 6. Fentanyl buccal tablet.
    Messina J, Darwish M, Fine PG.
    Drugs Today (Barc); 2008 Jan; 44(1):41-54. PubMed ID: 18301803
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. New strategies in opioid therapy for cancer pain.
    Cherny N.
    J Oncol Manag; 2000 Jan; 9(1):8-15. PubMed ID: 10787576
    [Abstract] [Full Text] [Related]

  • 9. Benefit-risk assessment of transdermal fentanyl for the treatment of chronic pain.
    Kornick CA, Santiago-Palma J, Moryl N, Payne R, Obbens EA.
    Drug Saf; 2003 Jan; 26(13):951-73. PubMed ID: 14583070
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Controlled-release oxycodone tablets after transdermal-based opioid therapy in patients with cancer and non-cancer pain.
    Ravera E, Di Santo S, Bosco R, Arboscello C, Chiarlone R.
    Aging Clin Exp Res; 2011 Jan; 23(5-6):328-32. PubMed ID: 22526067
    [Abstract] [Full Text] [Related]

  • 12. Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims.
    Karanges EA, Blanch B, Buckley NA, Pearson SA.
    Br J Clin Pharmacol; 2016 Jul; 82(1):255-67. PubMed ID: 26991673
    [Abstract] [Full Text] [Related]

  • 13. What is the case for prescribing long-acting opioids over short-acting opioids for patients with chronic pain? A critical review.
    Rauck RL.
    Pain Pract; 2009 Jul; 9(6):468-79. PubMed ID: 19874536
    [Abstract] [Full Text] [Related]

  • 14. Responsible prescribing of opioids for the management of chronic pain.
    Nicholson B.
    Drugs; 2003 Jul; 63(1):17-32. PubMed ID: 12487620
    [Abstract] [Full Text] [Related]

  • 15. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
    Trescot AM, Helm S, Hansen H, Benyamin R, Glaser SE, Adlaka R, Patel S, Manchikanti L.
    Pain Physician; 2008 Mar; 11(2 Suppl):S5-S62. PubMed ID: 18443640
    [Abstract] [Full Text] [Related]

  • 16. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM, Shi M, Buckley BJ, Kwarcinski MA.
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [Abstract] [Full Text] [Related]

  • 17. Pain treatment with opioids : achieving the minimal effective and the minimal interacting dose.
    Geppetti P, Benemei S.
    Clin Drug Investig; 2009 Jan; 29 Suppl 1():3-16. PubMed ID: 19445550
    [Abstract] [Full Text] [Related]

  • 18. Factors influencing quality of life in cancer patients: the role of transdermal fentanyl in the management of pain.
    Payne R.
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):47-53. PubMed ID: 9671331
    [Abstract] [Full Text] [Related]

  • 19. Opioid equianalgesic conversion: the right dose.
    Brant JM.
    Clin J Oncol Nurs; 2001 Jun; 5(4):163-5. PubMed ID: 12690618
    [Abstract] [Full Text] [Related]

  • 20. Opioid formulations: tailoring to the needs in chronic pain.
    Reder RF.
    Eur J Pain; 2001 Jun; 5 Suppl A():109-11. PubMed ID: 11798229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.